Talis Biomedical (NASDAQ:TLIS – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Insider & Institutional Ownership 47.1% of Talis Biomedical […]
Operator: Good day and thank you for standing by. Welcome to the Talis Biomedical s Business Update Conference Call. At this time, all participants are in a listen-only mode.
Talis Biomedical Co. (NASDAQ:TLIS – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 332,400 shares, a growth of 21.4% from the April 15th total of 273,900 shares. Based on an average trading volume of 85,900 shares, the […]
Talis Biomedical Co. (NASDAQ:TLIS – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 332,400 shares, a growth of 21.4% from the April 15th total of 273,900 shares. Approximately 1.4% of the shares of the stock are short sold. Based on an average daily […]
Talis Biomedical (NASDAQ:TLIS – Get Rating) is one of 43 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Talis Biomedical to similar businesses based on the strength of its analyst recommendations, risk, valuation, profitability, institutional ownership, dividends and earnings. Risk and Volatility Talis Biomedical has […]